Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGF with Silver Sulfadiazine for Partial Thickness Burns
NCT01553708Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- Dec 2011
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nepidermin in partial-thickness burn, sponsored by Chulalongkorn University. Primary endpoint: Time of Healing by Monitoring Duration at 28 days. Started Dec 2011; status: completed.
02
Drugs
nepidermin
03
Conditions
partial-thickness burn
Beyond the preview
Go deeper on NCT01553708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553708.